Company / R&D per Share
LivaNova R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$3.42
FY2025
5-year range
$2.87 / $3.62
FY2021-FY2025
Trend
+1.0%
vs FY2024
Sector context
#19 of 108
Health Care
What the data says
LivaNova's r&d per share of $3.42 is higher than 82% of companies in the Health Care sector (FY2025). R&D per Share has fluctuated over the past 10 years, ranging from $0.00 in FY2017 to $3.62 in FY2023.
Based on SEC 10-K filings.
3.42 in FY2025 with a 5-year CAGR of +1.6%. Top quartile in the Health Care sector.
Declined from $3.62 to $3.42 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +6.0%
- 5-Year CAGR
- +1.6%
- 10-Year CAGR
- -
Sector benchmark
Top 18% in Health CareTop 18% of 108This company $3.42 Sector average $2.07
▼
+64.8% above sector average
Key checks
Key Insights
- In FY2025, r&d per share increased 1.0% year-over-year.
- Ranks #19 out of 108 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2023.
- Lowest r&d per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.84 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.42 | +1.0% |
| FY2024 | $3.39 | -6.4% |
| FY2023 | $3.62 | +26.0% |
| FY2022 | $2.87 | -4.9% |
| FY2021 | $3.02 | -4.4% |
| FY2020 | $3.16 | +3.6% |
| FY2019 | $3.05 | +0.8% |
| FY2018 | $3.02 | +132451.8% |
| FY2017 | $0.00 | -99.9% |
| FY2016 | $3.16 | +146.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026